Daryl C Pope

Array ( [id] => 1236137 [patent_doc_number] => 06689812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders' [patent_app_type] => B2 [patent_app_number] => 10/014603 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10251 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689812.pdf [firstpage_image] =>[orig_patent_app_number] => 10014603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6158897 [patent_doc_number] => 20020147175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Synergistic ECTA compositions' [patent_app_type] => new [patent_app_number] => 09/990799 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19886 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147175.pdf [firstpage_image] =>[orig_patent_app_number] => 09990799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312052 [patent_doc_number] => 06613796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions' [patent_app_type] => B2 [patent_app_number] => 09/999291 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17671 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613796.pdf [firstpage_image] =>[orig_patent_app_number] => 09999291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969125 [patent_doc_number] => 20020091137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Use of CCI-779 as an antineoplastic agent' [patent_app_type] => new [patent_app_number] => 10/010584 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2886 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091137.pdf [firstpage_image] =>[orig_patent_app_number] => 10010584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815174 [patent_doc_number] => 20020040005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Composition and method of treating cancer' [patent_app_type] => new [patent_app_number] => 09/983444 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5239 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040005.pdf [firstpage_image] =>[orig_patent_app_number] => 09983444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236148 [patent_doc_number] => 06689815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Intratumoral use of dinitrochorobenzene: composition and use of injections including particular applications' [patent_app_type] => B2 [patent_app_number] => 09/978286 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1402 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689815.pdf [firstpage_image] =>[orig_patent_app_number] => 09978286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289783 [patent_doc_number] => 06632841 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Soluble compositions of triphenylethylene antiestrogens' [patent_app_type] => B1 [patent_app_number] => 09/868179 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3782 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632841.pdf [firstpage_image] =>[orig_patent_app_number] => 09868179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874878 [patent_doc_number] => 20020049231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Methods and compositions for inhibition of angiogenesis' [patent_app_type] => new [patent_app_number] => 09/966895 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6512 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049231.pdf [firstpage_image] =>[orig_patent_app_number] => 09966895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408806 [patent_doc_number] => 20020037917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Treatment of cancer using lipoic acid in combination with ascorbic acid' [patent_app_type] => new [patent_app_number] => 09/956525 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3810 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037917.pdf [firstpage_image] =>[orig_patent_app_number] => 09956525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999382 [patent_doc_number] => 20020028253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 09/951393 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 9086 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028253.pdf [firstpage_image] =>[orig_patent_app_number] => 09951393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291500 [patent_doc_number] => 06630454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-07 [patent_title] => 'Method and pharmaceutical composition for the treatment of cancer' [patent_app_type] => B2 [patent_app_number] => 09/948621 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9601 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630454.pdf [firstpage_image] =>[orig_patent_app_number] => 09948621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344295 [patent_doc_number] => 20020035134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Indoline derivatives useful as 5-HT-2C receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/948289 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4844 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035134.pdf [firstpage_image] =>[orig_patent_app_number] => 09948289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017102 [patent_doc_number] => 20020103218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Anhydrovinblastine for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/946149 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9071 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103218.pdf [firstpage_image] =>[orig_patent_app_number] => 09946149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1324432 [patent_doc_number] => 06599499 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Uses of diterpenoid triepoxides as an anti-proliferative agent' [patent_app_type] => B1 [patent_app_number] => 09/935794 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16142 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599499.pdf [firstpage_image] =>[orig_patent_app_number] => 09935794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631266 [patent_doc_number] => 06635666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-21 [patent_title] => 'Cancer treatment with epothilones' [patent_app_type] => B2 [patent_app_number] => 09/925119 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25695 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635666.pdf [firstpage_image] =>[orig_patent_app_number] => 09925119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064224 [patent_doc_number] => 20020032209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones' [patent_app_type] => new [patent_app_number] => 09/918040 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6166 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032209.pdf [firstpage_image] =>[orig_patent_app_number] => 09918040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625228 [patent_doc_number] => 20020016352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Cancer treatment with Go6976 and its related compounds' [patent_app_type] => new [patent_app_number] => 09/912758 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3333 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016352.pdf [firstpage_image] =>[orig_patent_app_number] => 09912758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001048 [patent_doc_number] => 20010053773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Method for inhibiting the growth of cancers' [patent_app_type] => new [patent_app_number] => 09/910982 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3381 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053773.pdf [firstpage_image] =>[orig_patent_app_number] => 09910982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360721 [patent_doc_number] => 06573292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Methods and compositions for the treatment of chronic lymphocytic leukemia' [patent_app_type] => B1 [patent_app_number] => 09/720992 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6441 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573292.pdf [firstpage_image] =>[orig_patent_app_number] => 09720992 [rel_patent_id] =>[rel_patent_doc_number] =>)